Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes.
暂无分享,去创建一个
M. Manns | M. Hust | A. Frenzel | M. Galla | E. Jaeckel | M. Hardtke-Wolenski | J. Dywicki | L. E. Buitrago-Molina | M. Hapke | K. Zimmermann | Michel Tenspolde | M. Lieber | Leonie C Weber | M. Hardtke‐Wolenski | L. E. Buitrago‐Molina | Janine Dywicki | Katharina Zimmermann | Melanie Galla